8-K: MetLife Exceeds 2025 Targets, Boosts Shareholder Returns

MetLife reported strong full-year and fourth-quarter 2025 results, surpassing key financial targets including adjusted EPS growth, free cash flow ratio, and direct expense ratio, while returning $4.4 billion to shareholders.

Summary

• Full-year net income was $3.2 billion, or $4.71 per share.
• Adjusted earnings per share, excluding total notable items, increased 10% to $8.89 for the full year, meeting the double-digit target.
• Premiums, fees and other revenues (PFOs) increased 10% to $57.6 billion for the full year.
• Adjusted PFOs, excluding pension risk transfers (PRT), were up 5% to $49.8 billion for the full year.
• Retirement and Income Solutions (RIS) achieved record sales, including $14.2 billion in PRT and $11.1 billion of U.K. longevity reinsurance.
• The two-year average free cash flow ratio of 81% (excluding total notable items) exceeded the 65-75% target.
• The full-year direct expense ratio of 11.7% (excluding total notable items related to direct expenses and PRT) beat the 12.1% target.
• Adjusted return on equity (ROE), excluding total notable items, was 16% for the full year, at the midpoint of the 15-17% target range.
• Book value per share (BVPS) increased 14% to $39.02, and adjusted BVPS increased 4% to $57.07.
• MetLife returned nearly $4.4 billion to shareholders in 2025 through share repurchases and common stock dividends.
• Holding company cash and liquid assets totaled $3.6 billion at year-end, within the $3.0 billion to $4.0 billion target range.
• Fourth-quarter adjusted earnings increased 13% to $1.6 billion, driven by variable investment income, strong volume growth, and improved expense margins.
• Fourth-quarter adjusted earnings per share, excluding total notable items, increased 24% to $2.58.
• MetLife Investment Management (MIM) total assets under management (AUM) were $741.7 billion, up 27%, primarily reflecting the acquisition of PineBridge Investments, which closed on December 30, 2025.
• The 2025 Combined NAIC Risk-Based Capital (RBC) ratio is estimated to be above MetLife's 360% target.
• The expected Japan Solvency Margin ratio at December 31, 2025, is approximately 770%.
• The estimated Economic Solvency Ratio is 170% to 190% for the fiscal year ending March 2026.

Sentiment

Score: 8

Explanation: StockSavvy.ai views this filing positively due to MetLife's strong financial performance, exceeding key targets, robust capital position, and strategic growth initiatives, despite a decline in GAAP net income.

Positives

• Full-year adjusted EPS growth of 10% (excluding notable items) met the double-digit target.
• Full-year adjusted return on equity (ROE) of 16% (excluding notable items) was at the midpoint of the 15-17% target range.
• Two-year average free cash flow ratio of 81% (excluding notable items) exceeded the 65-75% target.
• Full-year direct expense ratio of 11.7% (excluding total notable items related to direct expenses and PRT) beat the 12.1% target.
• Returned nearly $4.4 billion to shareholders in 2025 through share repurchases and common stock dividends.
• Holding company cash and liquid assets of $3.6 billion at year-end were within the $3.0 billion to $4.0 billion target range.
• Retirement and Income Solutions (RIS) achieved record sales, including $14.2 billion in pension risk transfers (PRT) and $11.1 billion in U.K. longevity reinsurance.
• MetLife Investment Management (MIM) total assets under management grew 27% to $741.7 billion, boosted by the PineBridge Investments acquisition.
• Strong capital position with 2025 Combined NAIC Risk-Based Capital (RBC) ratio above 360% target and Japan Solvency Margin ratio of ~770%.
• Fourth-quarter adjusted earnings increased 13% and adjusted EPS (excluding notable items) increased 24%.
• Group Benefits adjusted earnings increased 12% due to favorable life underwriting.
• RIS adjusted earnings increased 18% driven by favorable variable investment income.
• EMEA adjusted earnings increased 64% due to strong volume growth and favorable underwriting.
• MIM adjusted earnings increased 275% due to operating margins.

Negatives

• Full-year net income decreased 25% to $3.173 billion from $4.226 billion in 2024.
• Fourth-quarter net income decreased 37% to $778 million from $1.239 billion in the prior-year quarter, primarily due to net derivative losses and net investment losses.
• Latin America adjusted earnings decreased 1% on a reported basis and 9% on a constant currency basis, primarily reflecting a value-added tax adjustment in Mexico.
• Corporate & Other adjusted loss increased to $(70) million in Q4 2025 from $(62) million in Q4 2024.
• Full-year adjusted earnings were negatively impacted by notable items, primarily related to tax adjustments of ($0.1) billion and litigation reserves and settlement costs of ($0.03) billion.

Risks

• Continued uncertainty around inflation and unemployment in 2026.
• Reliance on the accuracy of assumptions about future economic and business conditions, which can be affected by known and unknown risks, uncertainties, and other factors.
• Economic condition difficulties, including risks relating to interest rates, credit spreads, declining equity or debt markets, changes in the value of assets under management, real estate, obligors and counterparties, government default or shutdown, currency exchange rates, derivatives, climate change, public health, terrorism and security.
• Global capital and credit market adversity.
• Credit facility inaccessibility.
• Financial strength or credit ratings downgrades.
• Unavailability, unaffordability, or inadequate reinsurance, including reinsurance risks that arise from reinsurers' credit risk, and the potential shortfall or failure of risk mitigants to protect against such risks.
• Statutory life insurance reserve financing costs or limited market capacity.
• Legal, regulatory, and supervisory and enforcement policy changes.
• Changes in tax rates, tax laws or interpretations.
• Litigation and regulatory investigations.
• Unsuccessful efforts to meet all sustainability standards or to enhance sustainability.
• Inability to pay dividends and repurchase common stock.
• Subsidiaries' inability to pay dividends to MetLife, Inc.
• Investment defaults, downgrades, or volatility.
• Investment sales or lending difficulties.
• Collateral or derivative-related payments.
• Investment valuations, allowances, or impairments changes.
• Claims or other results that differ from estimates, assumptions, or models.
• Global political, legal, or operational risks.
• Business competition.
• Technological changes.
• Catastrophes.
• Climate changes or responses to it.
• Deficiencies in the closed block.
• Goodwill or other asset impairment, or deferred income tax asset allowance.
• Impairment of VOBA, value of distribution agreements acquired or value of customer relationships acquired.
• Product guarantee volatility, costs, and counterparty risks.
• Risk management failures.
• Insufficient protection from operational risks.
• Failure to protect confidentiality, integrity or availability of systems or data or other cybersecurity or disaster recovery failures.
• Accounting standards changes.
• Excessive risk-taking.
• Marketing and distribution difficulties.
• Pension and other postretirement benefit assumption changes.
• Inability to protect intellectual property or avoid infringement claims.
• Acquisition, integration, growth, disposition, or reorganization difficulties.
• Brighthouse Financial, Inc. separation risks.
• MetLife, Inc.'s Board of Directors' influence over the outcome of stockholder votes through the voting provisions of the MetLife Policyholder Trust.
• Legaland corporate governance-related effects on business combinations.

Future Outlook

MetLife anticipates a relatively stable U.S. dollar in 2026 compared to 2025, with long-term interest rates moderately rising and the yield curve steepening as short-term rates decline, based on the forward yield curve as of December 31, 2025. The company expects to maintain its holding company cash target of $3.0 billion to $4.0 billion and is on track to generate approximately $25.0 billion in free cash flow from 2025 to 2029. For 2026, MetLife maintains near-term annual targets of 15%-17% adjusted return on equity (excluding notable items) and double-digit adjusted earnings per share growth (excluding notable items). It is committed to achieving a direct expense ratio target of 12.1% for 2026 and 11.3% in 2029, while continuing its New Frontier strategy.

Management Comments

• "MetLife delivered record fourth quarter results, underscoring the strength of our diversified businesses and the disciplined execution of our all-weather New Frontier strategy."
• "For the full year, we achieved 10% adjusted earnings per share growth, 16% adjusted return on equity, and beat our direct expense and free cash flow ratio targets, while returning nearly $4.4 billion to shareholders."
• "We made significant progress in advancing our New Frontier priorities, completing key strategic transactions and entering new partnerships to extend our market leadership, expand our global reach, and enhance capital flexibility."
• "We are confident that the foundation built in 2025 positions MetLife to accelerate growth responsibly and deploy capital prudently to deliver on our New Frontier commitments."

Industry Context

StockSavvy.ai notes that MetLife's strong performance in pension risk transfers and U.K. longevity reinsurance reflects a robust institutional market for de-risking solutions, a trend observed across the global insurance industry as companies seek to offload pension liabilities. The acquisition of PineBridge Investments also signals a strategic move to expand asset management capabilities, aligning with a broader industry trend of insurers diversifying revenue streams through third-party asset management. The focus on expense discipline and efficiency, as evidenced by beating direct expense ratio targets, is a common theme among established financial services firms navigating competitive pressures and evolving regulatory landscapes.

Comparison to Industry Standards

• MetLife's 16% adjusted ROE (excluding notable items) for 2025 is competitive within the life insurance and annuities sector, often compared to peers like Prudential Financial (PRU) or Aflac (AFL), which typically aim for mid-to-high teens ROE.
• The 81% two-year average free cash flow ratio (excluding notable items) significantly exceeds its 65-75% target, indicating strong cash generation capabilities relative to its adjusted earnings, a metric closely watched by investors for capital deployment flexibility.
• The direct expense ratio of 11.7% (excluding notable items and PRT) beating the 12.1% target demonstrates effective cost management, which is crucial in a mature industry where efficiency drives profitability.
• The 27% growth in Total Assets Under Management (AUM) to $741.7 billion, largely due to the PineBridge Investments acquisition, positions MetLife Investment Management (MIM) as a significant player, comparable to the asset management arms of other large insurers like BlackRock (BLK) or Vanguard, though MIM's scale is still smaller than these pure-play asset managers.

Legal Proceedings

• Litigation reserves and settlement costs of $(32) million for Q4 2025 and $(32) million for full year 2025 (negative impact to adjusted earnings).
• Litigation and regulatory investigations are listed as a risk factor.

Stakeholder Impact

• Shareholders: Positive impact from strong financial performance, meeting/exceeding targets, and significant capital returns ($4.4 billion in 2025). Potential for continued share repurchases and dividends.
• Employees: Continued focus on expense discipline and efficiency mindset may imply ongoing scrutiny of operational costs.
• Customers: Continued execution of the "New Frontier strategy" aims to extend market leadership and expand global reach, potentially benefiting customers through broader offerings and enhanced services.
• Creditors: Strong capitalization and liquidity position, with no expected material liquidity deficiencies and compliance with financial covenants, provides assurance.

Next Steps

• Maintain holding company cash target of $3.0 billion to $4.0 billion in 2026.
• Continue reviewing accounting estimates, asset valuations, and various financial scenarios for capital and liquidity implications.
• Maintain near-term annual targets for adjusted return on equity (15%-17%) and double-digit adjusted earnings per share growth (excluding total notable items).
• Achieve a direct expense ratio target of 12.1% for 2026 and 11.3% in 2029.
• Remain fully committed to the New Frontier strategy.
• Conduct combined fourth quarter and full year 2025 earnings and outlook conference call on February 5, 2026.
• Expect 2026 share repurchases to be in line with 2025.
• MIM expects 1Q26 adjusted earnings to be ~$50 million due to higher seasonal expenses.
• MIM expects revenues to grow ~30% in 2026 and mid-single digits thereafter.
• MIM expects adjusted earnings to be between $240 million-$280 million in 2026 and grow 15-20% in 2027 and 2028.
• Group Benefits adjusted PFOs expected to grow 4-7% in 2026.
• Group Benefits adjusted earnings (excluding notable items) expected to grow 7-9% in 2026.
• RIS adjusted earnings expected to be $1.6B-$1.8B in 2026.
• RIS general account investment spread expected to be 100-120 bps in 2026.
• Asia sales growth of mid-to-high single digits and general account AUM to grow mid single-digits in 2026.
• Asia adjusted earnings (excluding notable items) to grow mid single-digits in 2026.
• Latin America adjusted PFOs expected to grow high single digits and adjusted earnings (excluding notable items) to grow 6-8% in 2026 and high-single digits thereafter.
• EMEA adjusted PFOs expected to grow high single digits in 2026.
• EMEA adjusted earnings run rate of $90M-$100M per quarter in 2026, and expected to grow mid-to-high single digits in 2027 and 2028.

Key Dates

Recommendation

The filing demonstrates MetLife's robust financial health and strategic execution, consistently meeting or exceeding key performance targets like adjusted EPS growth, ROE, free cash flow, and expense ratios. The significant capital return to shareholders ($4.4 billion) and strong capital position (RBC ratio above target, high solvency margin) indicate a well-managed company with ample financial flexibility. The positive outlook for 2026 and beyond, coupled with strategic acquisitions like PineBridge Investments, suggests continued growth and value creation. Despite a GAAP net income decline, the adjusted earnings metrics, which management emphasizes, show a healthy underlying business trajectory. These factors collectively present a compelling investment case for long-term growth and shareholder returns.

Keywords

Insurance, Annuities, Employee Benefits, Asset Management, Financial Services, MetLife, MET, SEC Filing, Earnings, Financial Results, Q4 2025, Full Year 2025, Adjusted Earnings, EPS, ROE, Free Cash Flow, Direct Expense Ratio, AUM, Pension Risk Transfer, Longevity Reinsurance, Capital, Liquidity, Outlook, PineBridge Investments